Concepedia

Matthias Beyens

MB

Statistics

Publications

11

Citations

643

H-Index

11

Active since

2015

Affiliations

University of Antwerp(Current)

Antwerp University Hospital

Statistics Belgium

Erasmus MC

Baylor College of Medicine

Matthias Beyens is an author at University of Antwerp specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2015–2019

11

Publications

11

Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1

Timon Vandamme, Marc Peeters, Fadime Dogan et al. · Journal of Molecular Endocrinology · 2015 · 108 citations · Full text

, , +17

Large-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancer

Lieselot Croes, Matthias Beyens, Erik Fransén et al. · Clinical Epigenetics · 2018 · 106 citations · Full text

, , +17

Inhibitory actions of the NRG-1/ErbB4 pathway in macrophages during tissue fibrosis in the heart, skin, and lung

Zarha Vermeulen, Anne-Sophie Hervent, Lindsey Dugaucquier et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2017 · 87 citations · Full text

, , +11

Methylation analysis of <i>Gasdermin E</i> shows great promise as a biomarker for colorectal cancer

Joe Ibrahim, Ken Op de Beeck, Erik Fransén et al. · Cancer Medicine · 2019 · 79 citations · Full text

, , +17

Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors

Timon Vandamme, Matthias Beyens, Ken Op de Beeck et al. · British Journal of Cancer · 2016 · 74 citations · Full text

, , +17

1–5 of 11